Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
Clinical trial NCT02445586 · COMPLETED
Trial details
- NCT number
- NCT02445586
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-17
- Primary completion
- 2018-09-26
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.